Biopticon Corporation
Discovery through Imaging
Discovery through Imaging
Biopticon Corporation is a United States-based startup that specializes in developing state-of-the-art scanning devices and data management software for preclinical research studies. The company's flagship product, Tumor Imager-2, is a handheld imager designed for subcutaneous tumors, providing accurate surface measurements and real-color 3D images. Additionally, their TumorManager software seamlessly integrates study protocols and produces comprehensive metrics, statistical analyses, and publishable reports.
The company was founded in 2007 and operates within the Manufacturing and Medical Devices industries. Their most recent investment was a Venture Round investment by NJEDA on 23 January 2009.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 |
|
23 Jan 2009 |
No recent news or press coverage available for Biopticon Corporation.
We care about your data, and we'd love to use cookies make your experience better.
